Despite the limitations of real-world observational studiesincluding the absence of randomization, control for confounding variables, and inability to establish causalityresearches offer confidence regarding the pancreatic safety profiles of GLP-1 RAs [55,61]
At La Jolla Recovery, we closely follow emerging science that could reshape how we understand and treat addiction
TRIUMPH-1 (80 weeks, general obesity, n=2,339): 28.3% average weight loss at 12mg dose
Accessing Treatment: Where Does Retatrutide Stand
As a result, youre likely to feel satisfied with less food, which can lead to a lower calorie intake and support sustained weight loss
Notably, tirzepatide is characterised in the literature as an imbalanced or biased dual agonist: its affinity for the GIP receptor is comparable to native GIP, while its affinity for the GLP-1 receptor is roughly 18- to 20-fold weaker than native GLP-1